Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 1

Status

Completed 6Terminated 1

Sponsor Class

OTHER 31NIH 19NETWORK 7INDUSTRY 5

Study Type

Interventional 7

Sponsor

Cancer Type

Other hematologic neoplasm 59Lymphoid 58Sarcoma 10Genitourinary 7Breast 7Myeloid 5Classical hematology 4CNS 4Dermatologic 3Tumor-Agnostic 1Plasma cell 1Head & Neck 1Gynecologic 1

Conditions

Breast Neoplasms 7Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
NETWORK × Methotrexate × Breast × Clear all
NCT00036868 2024-03-08

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
90 enrolled
Breast

Breast Neoplasms

NCT00309478 2023-06-29

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Austrian Breast & Colorectal Cancer Study Group

Phase 3 Completed
1,099 enrolled
Breast

Breast Neoplasms

NCT00296010 2021-02-23

CASA

ETOP IBCSG Partners Foundation

Phase 3 Terminated
77 enrolled
Breast

Breast Neoplasms

NCT00309569 2020-10-14

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

Austrian Breast & Colorectal Cancer Study Group

Phase 3 Completed
429 enrolled
Breast

Breast Neoplasms

NCT00002542 2020-04-01

Tamoxifen in Treating Women With High-Risk Breast Cancer

Canadian Cancer Trials Group

Phase 3 Completed
672 enrolled
Breast

Breast Neoplasms

NCT00022516 2016-09-16

22-00

ETOP IBCSG Partners Foundation

Phase 3 Completed
1,086 enrolled 10 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00002784 2013-04-04

15-95

ETOP IBCSG Partners Foundation

Phase 3 Completed
344 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡